Aidian Oy

Aidian Oy Aidian develops, manufactures, and markets diagnostic test systems for healthcare professionals.

Meet us at WONCA Europe Conference 2026!📍 Le Palais des Congrès, Paris🗓️ 30 June - 3 JulyWe warmly invite you to visit u...
03/06/2026

Meet us at WONCA Europe Conference 2026!

📍 Le Palais des Congrès, Paris
🗓️ 30 June - 3 July

We warmly invite you to visit us at booth 15 at this year’s WONCA Europe Conference. Come and meet our team and discover the QuikRead go Plus Instrument.

QuikRead go Plus enables effortless point-of-care testing (POCT) and supports fast clinical decision-making by delivering laboratory-quality results in minutes.

We look forward to meeting you in Paris! 👋

Welcome Torben Nielsen, our new CEOThis week we had the pleasure of welcoming our new CEO, Torben Nielsen, as he started...
02/06/2026

Welcome Torben Nielsen, our new CEO

This week we had the pleasure of welcoming our new CEO, Torben Nielsen, as he started his role at Aidian. During a Town Hall meeting in Espoo, Torben introduced himself to the team and spoke about his vision for the future. He shared what drew him to Aidian, highlighting the meaningful mission in diagnostics, and shared his excitement about building the next chapter together.

Jesper Mailind, Chair of the Board of Directors of Aidian, also shared his enthusiasm during the Town Hall, highlighting Torben’s strong professional background, as well as his international leadership experience.

We are excited to have Torben on board and look forward to the journey ahead together. Join us in welcoming Torben to the Aidian team! 💙

➡️ https://www.aidian.eu/news/welcome-torben-nielsen-our-new-ceo

27/05/2026

🕷️ Preparing for tick season with reliable diagnostics 🧪

Tick-borne diseases are increasing across Europe. Longer and warmer seasons are supporting higher tick activity and gradual expansion into new areas, leading to growing demand for diagnostics.

Infected ticks may transmit pathogens causing:
• Tick-borne encephalitis
• Lyme borreliosis
• Lyme neuroborreliosis

Early and reliable diagnostics matter, as symptoms can be non-specific and variable, making clinical diagnosis challenging. Accurate point-of-care testing (POCT) supports fast clinical decision-making and appropriate patient management.

Be ready for the season. With increasing awareness and testing demand, having the right diagnostics in place is essential.

Aidian distributes Mikrogen products in the Benelux and Nordic countries, and Reagena products in Scandinavia.

For more information please contact our team. Download also our flyer on tick-borne infection diagnostics from our website:
➡️ https://www.aidian.eu/news/preparing-for-tick-season-with-reliable-diagnostics

New insights for implementing C-reactive protein point-of-care testingIn Belgium, C-reactive protein ( ) point-of-care t...
26/05/2026

New insights for implementing C-reactive protein point-of-care testing

In Belgium, C-reactive protein ( ) point-of-care testing (POCT) has not yet been widely implemented in primary care. Although scientific evidence shows that CRP POCT can help reduce unnecessary antibiotic prescribing in adults with acute cough, successful national adoption requires also understanding about the practical, organizational, and economic factors.

To investigate whether CRP POCT could be integrated into Belgian primary care workflows, an implementation project was conducted using focus group discussions with general practitioners and other relevant key stakeholders to address what barriers and facilitators should be considered before wider adoption. QuikRead go easy CRP was one of the CRP POCT devices included in the project.

The findings show that CRP POCT fits well into general practitioner’s workflows and supports antimicrobial stewardship by helping physicians make more informed decisions on antibiotic prescribing. Physicians considered CRP POCT valuable particularly in three areas:

✅ Reducing diagnostic uncertainty and supporting treatment decisions
✅ Supporting patient communication especially in situation when antibiotics are not needed
✅ Supporting decision making and reassurance of parents in paediatric care

For successful wider implementation, the study also points out the importance of clear guidelines, quality control, streamlined workflows and centralized support structures.

At , we are proud that QuikRead go easy CRP was part of this project, which provides valuable real-world evidence on the role of CRP POCT in supporting clinical decision-making, responsible antibiotic use, and patient care.

Read more from our website:
➡️ https://www.aidian.eu/insights-hub/highlights/real-world-insights-on-c-reactive-protein-point-of-care-testing-lessons-from-a-belgian-implementation-study

Hantavirus Andes outbreak and diagnosticsRecent reports highlight an outbreak caused by the Andes hantavirus, underscori...
18/05/2026

Hantavirus Andes outbreak and diagnostics

Recent reports highlight an outbreak caused by the Andes hantavirus, underscoring the importance of reliable diagnostics in emerging situations.

At Aidian, we distribute Reagena hantavirus diagnostic tests in Scandinavia.

A study by Navarrete et al. (2007) demonstrated that the Reagena POC Puumala IgM rapid test can efficiently detect Andes virus infections, despite being originally developed for Puumala virus.

This is explained by the high antigen cross reactivity between hantaviruses, which can support detection beyond a single strain.

👉 In practice, this means such assays support:
• Early screening in suspected hantavirus infections
• Diagnostic preparedness when the circulating strain is unknown

Visit our website for more details:
➡️ https://www.aidian.eu/news/hantavirus-andes-outbreak-and-diagnostics

Our Sustainability Report 2025 is now published 🌍 We are pleased to share our Sustainability Report presenting our susta...
13/05/2026

Our Sustainability Report 2025 is now published 🌍

We are pleased to share our Sustainability Report presenting our sustainability performance and priorities during year 2025. The report is prepared in accordance with the VSME standard to support transparent and proportionate sustainability reporting.

Some highlights from year 2025 include:
✔️ Refinement of greenhouse gas (GHG) emission calculations
✔️ Update of sustainability policies and development of a Sustainability Action Plan
✔️ Strengthening of leadership principles and update of our values to support our people and ways of working
✔️ Renewal of the Mental Health Friendly Workplace label, granted by MIELI Mental Health Finland

Visit our website for the full report:
➡️ https://www.aidian.eu/news/aidians-sustainability-report-2025-is-now-published

Point-of-care testing goes beyond speed to support patient careHealthcare systems across Europe are under constant press...
07/05/2026

Point-of-care testing goes beyond speed to support patient care

Healthcare systems across Europe are under constant pressure from staff shortages, growing patient volumes, and tighter budgets. A whitepaper by the German diagnostics industry association VDGH highlights point-of-care testing (POCT) as a practical way to ease that pressure by enabling faster, smarter decisions closer to the patient.

When results are available immediately:
✅ Physicians can make informed decisions
✅ Workflows become simpler and more efficient
✅ Targeted diagnostics support responsible antibiotic use
✅ Patients benefit from clearer communication

At Aidian, we see POCT as a key building block for resilient healthcare systems, supporting reliable results and efficient workflows in everyday clinical practice.

Read more insights from the whitepaper on our website:
➡️ https://www.aidian.eu/insights-hub/highlights/point-of-care-testing-supporting-faster-clinical-decisions

New US study adds to the scientific evidence on CRP in respiratory infectionsWhen patients present with acute lower resp...
29/04/2026

New US study adds to the scientific evidence on CRP in respiratory infections

When patients present with acute lower respiratory symptoms, the clinical picture is not always clear, leading to diagnostic uncertainty.

A study conducted in the US population with QuikRead go CRP provides further scientific evidence on the association between C-reactive protein (CRP) levels and clinical assessment in respiratory infections.

The findings reported that elevated CRP was associated with pneumonia and with longer and more severe illness. In addition, the GRACE risk score, which includes CRP, was validated in the US population and showed the strong performance for identifying community-acquired pneumonia. These results contribute to the scientific understanding of CRP as one parameter evaluated alongside other clinical findings.

Read the full story about the differences in CRP testing between Europe and the USA, the more detailed study findings, and the scientific context of QuikRead go CRP in the management of lower respiratory tract infections.

➡️ https://www.aidian.eu/news/new-us-study-strengthens-the-scientific-evidence-on-crp-in-lower-respiratory-tract-infections

The study referenced in this post was conducted using the US cleared version of QuikRead go CRP. Product versions and intended use may differ outside the US. Please consult local Instructions for Use.

International Mother Earth Day reminds us of our responsibility to protect our planet and to support sustainable develop...
22/04/2026

International Mother Earth Day reminds us of our responsibility to protect our planet and to support sustainable development that benefits both people and the Earth. 🌍🌱

At Aidian, we believe progress towards sustainability is built through practical steps and continuous improvement. By identifying the key environmental aspects of our operations, we focus on the areas where our actions matter most and work towards more responsible practices.

We develop diagnostic solutions supporting quality, reliability, and informed decision‑making across healthcare. Accurate and timely diagnostics support healthcare professionals in their daily practice and contribute to healthier lives and more resilient healthcare systems.

We believe caring for our planet goes hand in hand with caring for our health. Our aim is to improve lives while contributing to a more sustainable future for both people and the planet. 🌏

ReaScan+ point-of-care testing shows potential to improve diagnosis of neuroborreliosis in children with peripheral faci...
13/04/2026

ReaScan+ point-of-care testing shows potential to improve diagnosis of neuroborreliosis in children with peripheral facial palsy

A recent diagnostic accuracy study by Bloch et al. evaluated the ReaScan+ Lyme IgM/IgG point-of-care test in children with peripheral facial palsy. The study found good diagnostic accuracy, with results comparable to conventional laboratory serology. Importantly, the test provided results in around 30 minutes, supporting faster clinical decision-making.

When a child presents with peripheral facial palsy, faster diagnostic test result may help clinicians assess the likelihood of neuroborreliosis faster, support treatment decisions, and improve overall management of these patients.

While point-of-care testing does not replace clinical judgement or established diagnostic work-up, studies like this increase the growing evidence that rapid testing can support more efficient and responsive care pathways.

At Aidian, as the distributor of the Reagena ReaScan+ Lyme IgM/IgG point-of-care test in Scandinavia, we are pleased to see new promising evidence that supports the clinical utility in the rapid assessment of suspected neuroborreliosis.

See more detailed study results from our website:
➡️ https://www.aidian.eu/news/new-study-highlights-the-potential-of-point-of-care-testing-in-the-diagnosis-of-neuroborreliosis-in-children-with-peripheral-facial-palsy

Osoite

Koivu-Mankkaan Tie 6 B
Espoo
02200

Hälytykset

Tiedä ensimmäisenä ja anna meille oikeus lähettää sinulle sähköpostitse uutisia ja promootioita Aidian Oy :ltä. Sähköpostiosoitettasi ei käytetä muihin tarkoituksiin, ja voit perua milloin tahansa.

Ota Yhteyttä Yritys

Lähetä viesti Aidian Oy :lle:

Jaa